These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28894354)

  • 1. Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction.
    Beck DER; El-Assal K; McGarry K; Wride NK
    Clin Ophthalmol; 2017; 11():1565-1566. PubMed ID: 28894354
    [No Abstract]   [Full Text] [Related]  

  • 2. Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction.
    Muñoz Negrete FJ; Lemij HG; Erb C
    Clin Ophthalmol; 2017; 11():557-566. PubMed ID: 28356710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum: Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction [Corrigendum].
    Clin Ophthalmol; 2017; 11():887. PubMed ID: 28546739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication.
    Uusitalo H; Chen E; Pfeiffer N; Brignole-Baudouin F; Kaarniranta K; Leino M; Puska P; Palmgren E; Hamacher T; Hofmann G; Petzold G; Richter U; Riedel T; Winter M; Ropo A
    Acta Ophthalmol; 2010 May; 88(3):329-36. PubMed ID: 20546237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials.
    Uusitalo H; Egorov E; Kaarniranta K; Astakhov Y; Ropo A
    Clin Ophthalmol; 2016; 10():445-54. PubMed ID: 27041987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost.
    Tokuda N; Kitaoka Y; Matsuzawa A; Tsukamoto A; Sase K; Sakae S; Takagi H
    J Ophthalmol; 2017; 2017():3540749. PubMed ID: 28831305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension.
    Misiuk-Hojlo M; Pomorska M; Mulak M; Rekas M; Wierzbowska J; Prost M; Wasyluk J; Lubinski W; Podboraczynska-Jodko K; Romaniuk W; Kinasz R; Ortyl-Markiewicz R; Mocko L; Zaleska-Zmijewska A; Rokicki D; Baudouin C
    Eur J Ophthalmol; 2019 Mar; 29(2):210-215. PubMed ID: 29998767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy.
    Konstas AG; Boboridis KG; Kapis P; Marinopoulos K; Voudouragkaki IC; Panayiotou D; Mikropoulos DG; Pagkalidou E; Haidich AB; Katsanos A; Quaranta L
    Adv Ther; 2017 Jan; 34(1):221-235. PubMed ID: 27913991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients.
    Kestelyn PA; Kestelyn PG; De Bacquer D; Stevens AM
    Int Ophthalmol; 2019 Jan; 39(1):105-109. PubMed ID: 29274019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular Tolerability of Preservative-Free Tafluprost and Latanoprost: in vitro and in vivo Comparative Study.
    Esaki Y; Shimazaki A; Pellinen P
    Open Ophthalmol J; 2016; 10():146-53. PubMed ID: 27347250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension.
    Aptel F; Choudhry R; Stalmans I
    Curr Med Res Opin; 2016 Aug; 32(8):1457-63. PubMed ID: 27310103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost.
    Martinez-de-la-Casa JM; Perez-Bartolome F; Urcelay E; Santiago JL; Moreno-Montañes J; Arriola-Villalobos P; Benitez-Del-Castillo JM; Garcia-Feijoo J
    Ocul Surf; 2017 Oct; 15(4):723-729. PubMed ID: 28342814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystoid macular edema associated with preservative-free latanoprost after uncomplicated cataract surgery: case report and review of the literature.
    Makri OE; Tsapardoni FN; Plotas P; Ifantis N; Xanthopoulou PT; Georgakopoulos CD
    BMC Res Notes; 2017 Mar; 10(1):127. PubMed ID: 28320481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
    Kahook MY; Noecker RJ
    Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of a preservative-free latanoprost cationic emulsion (Catioprost) and a BAK-preserved latanoprost solution in animal models.
    Daull P; Buggage R; Lambert G; Faure MO; Serle J; Wang RF; Garrigue JS
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):515-23. PubMed ID: 22671995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular surface tolerability of prostaglandin analogs and prostamides in patients with glaucoma or ocular hypertension.
    Crichton AC; Vold S; Williams JM; Hollander DA
    Adv Ther; 2013 Mar; 30(3):260-70. PubMed ID: 23475405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial.
    Stalmans I; Oddone F; Cordeiro MF; Hommer A; Montesano G; Ribeiro L; Sunaric-Mégevand G; Rossetti L
    Graefes Arch Clin Exp Ophthalmol; 2016 Jun; 254(6):1151-8. PubMed ID: 26907933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability, quality of life, and persistency of use in patients with glaucoma who are switched to the fixed combination of latanoprost and timolol.
    Dunker S; Schmucker A; Maier H;
    Adv Ther; 2007; 24(2):376-86. PubMed ID: 17565929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
    Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
    J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma.
    Walimbe T; Chelerkar V; Bhagat P; Joshi A; Raut A
    Clin Ophthalmol; 2016; 10():821-7. PubMed ID: 27274186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.